The elusiveness of “normal” ALT in fatty liver
Open Access
- 25 March 2004
- journal article
- other
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 39 (4), 1172
- https://doi.org/10.1002/hep.20187
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- 106 International, multicenter, randomized, controlled study for the treatment of patients with chronic hepatitis C and persistently normal ALT levels with peginterferon alfa-2A (40KD) (PEGASYS®) and ribavirin (copegus®)Hepatology, 2003
- Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT valuesHepatology, 2003
- AGA technical review on nonalcoholic fatty liver diseaseGastroenterology, 2002
- A constellation of cardiovascular risk factors is associated with hepatic enzyme elevation in hyperlipidemic patientsMetabolism, 2002
- Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase LevelsAnnals of Internal Medicine, 2002
- Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinomaGastroenterology, 2002
- A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver diseaseComparative Hepatology, 2002
- Prevalence of Obesity and Diabetes in Patients With Cryptogenic Cirrhosis: A Case-Control StudyHepatology, 2000
- Liver fibrosis in overweight patientsGastroenterology, 2000
- Factors associated with serum alanine transaminase activity in healthy subjects: Consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis CHepatology, 1998